000 -LEADER |
fixed length control field |
03522nam a22004453a 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20150712005455.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
950321s1994 enk||||| 00||0 eng d |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
gb 94080538 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0851864945 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0851864945 (pbk.) |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
CaOON |
Language of cataloging |
eng |
Transcribing agency |
CaOON |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS403 |
Item number |
.M38 1994 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS403 |
Item number |
.M44 1994 |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
1994 K-866 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 744 |
Item number |
M4894 1994 |
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
RS403 |
Item number |
.M38 1994 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
084 ## - OTHER CLASSIFICATION NUMBER |
Classification number |
615.19 |
Item number |
K M |
001 - CONTROL NUMBER |
control field |
0000032687 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
0000 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
King, Frank D. |
245 10 - TITLE STATEMENT |
Title |
Medicinal chemistry |
Medium |
[Book :] |
Remainder of title |
principles and practice / |
Statement of responsibility, etc. |
edited by Frank D. King. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc. |
Cambridge [England] : |
Name of publisher, distributor, etc. |
Royal Society of Chemistry, |
Date of publication, distribution, etc. |
c1994. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xxi, 313 p. : |
Other physical details |
ill. ; |
Dimensions |
24 cm. |
500 ## - GENERAL NOTE |
General note |
Lectures presented at the 7th RSC Medicinal Chemistry School held June 28th-July 3rd 1993, at the University of Kent, Canterbury, UK.--Cf. pref. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and subject index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Ch. 1. An Introduction to Drug-Receptor Interactions / Barry Hunt -- Ch. 2. Signal Transduction and Second Messengers / Trevor J. Franklin -- Ch. 3. Enzyme Inhibitors / David A. Roberts -- Ch. 4. The Biological Evaluation of New Compounds / Robert A. Coleman -- Ch. 5. Pharmacokinetics / Robert M. J. Ings -- Ch. 6. Drug Metabolism / Colin Vose -- Ch. 7. Physicochemical Properties and Drug Design / Nigel P. Gensmantel -- Ch. 8. Quantitative Structure - Activity Relationships / Andrew M. Davis -- Ch. 9. Considerations for the Use of Computational Chemistry Techniques by Medicinal Chemists / Mike M. Hann -- Ch. 10. 'Patent Medicine' / Bill Tyrrell -- Ch. 11. Molecular Biology - A New Route to Drug Discovery / Janet E. Carey -- Ch. 12. Devising a Research Strategy / Colin W. Greengrass -- Ch. 13. Past Approaches to Discovering New Drugs as Medicines / C. Robin Ganellin. |
505 8# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Ch. 14. Bioisosteres, Conformational Restriction and Pro-drugs: Approaches to Lead Optimisation - Case History: An Example of a Conformational Restriction Approach / Frank D. King -- Ch. 15. The Design and Synthesis of Selective Protein Kinase C Inhibitors / Christopher H. Hill -- Ch. 16. Discovery of 1069C - A Novel Synthetic Antitumour Agent with Low Cross-Resistance Potential / Simon T. Hodgson -- Ch. 17. The Design and Biological Properties of 'Dipeptoid' Antagonists / David C. Horwell -- Ch. 18. Migraine Therapy - from Serotonin to Sumatriptan / Peter C. North -- Ch. 19. Drug Development / Jane Ormerod -- App. 1. Summary of Receptor Properties -- App. 2. Summary of Ion Channel Properties -- App. 3. Enzyme Commission Classification of Enzymes -- App. 4. Schematic Representations of Mechanisms of Proteases -- App. 5. Table of Substituent Constant [pi], MR, F, R, and [sigma] -- App. 6. An Example of a Craig Diagram Plot of [sigma] vs. [pi]. |
505 8# - FORMATTED CONTENTS NOTE |
Formatted contents note |
App. 7. Summary of Common Routes of Administration -- App. 8. Approximate Conversion Factors for [Delta]log to Ratio -- App. 9. Conversion Factors for Solutions and Dosages: Molar vs. Weight. |
521 ## - TARGET AUDIENCE NOTE |
Target audience note |
All Ages. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmaceutical chemistry. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Chemistry, Pharmaceutical |
General subdivision |
congresses. |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Chimie pharmaceutique |
General subdivision |
Congr?es. |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmaceutical chemistry |
General subdivision |
Congresses. |
700 10 - ADDED ENTRY--PERSONAL NAME |
Personal name |
King, Frank D. |
710 20 - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
Royal Society of Chemistry (Great Britain) |
711 20 - ADDED ENTRY--MEETING NAME |
Meeting name or jurisdiction name as entry element |
RSC Medicinal Chemistry School |
Number of part/section/meeting |
(7th : |
Date of meeting |
1993 : |
Location of meeting |
Canterbury, England) |
990 10 - EQUIVALENCES OR CROSS-REFERENCES [LOCAL, CANADA] |
Link information for 9XX fields |
91001a |
Link information for field corresponding to 9XX field |
71001a |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Books |